# A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

> **NCT07427797** · PHASE3 · RECRUITING · sponsor: **Ipsen** · enrollment: 300 (estimated)

## Conditions studied

- Moderate to Severe Glabellar Lines

## Interventions

- **BIOLOGICAL:** IPN10200
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT07427797
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-27
- **Primary completion:** 2026-12-15
- **Final completion:** 2027-07-15
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07427797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07427797, "A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07427797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*